Radiotherapy Combined Chimeric Antigen Receptor T-Cells Therapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma(R/R DLBCL)

被引：0
|
作者：
Zhou, Lili [1 ]
Liu, Yifan [1 ]
Ye, Shiguang [1 ]
Li, Ping [1 ]
Li, Shaoguang [2 ]
Liang, Aibin [1 ]
机构：
[1] Tongji Univ, Tongji Hosp, Dept Hematol, Shanghai, Peoples R China
[2] Univ Massachusetts, Sch Med, Worcester, MA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184352
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review
    Tian, Linyan
    Li, Cheng
    Sun, Juan
    Zhai, Yixin
    Wang, Jinhuan
    Liu, Su
    Jiang, Yanan
    Wu, Wenqi
    Xing, Donghui
    Lv, Yangyang
    Guo, Jing
    Xu, Hong
    Sun, Huimeng
    Li, Yuhang
    Li, Lanfang
    Zhao, Zhigang
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [32] Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma
    Seyedin, Roxanna
    Snider, Julia T.
    Rajagopalan, Krithika
    Wade, Sally W.
    Gergis, Usama
    FUTURE ONCOLOGY, 2023, 19 (22) : 1535 - 1547
  • [33] Interim evaluation of a targeted radiotherapeutic, CLR 131, in relapsed/refractory diffuse large B-cell lymphoma patients (R/R DLBCL)
    Longcor, J.
    Oliver, K.
    Friend, J.
    Callandar, N.
    ANNALS OF ONCOLOGY, 2019, 30 : 435 - 435
  • [34] Management of Canadian Patients (Pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) in the Real-World
    Peters, Anthea
    Nowakowski, Grzegorz S.
    Dabas, Rosy
    Amoloja, Theresa
    Xue, Zhenyi
    Koch, Caroline
    Waltl, Eva E.
    Fleury, Isabelle
    BLOOD, 2022, 140 : 3811 - 3813
  • [35] Clinical pharmacology of tisagenlecleucel (CTL019) in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL)
    Awasthi, Rakesh
    Tam, Constantine S.
    Jaeger, Ulrich
    Jaglowski, Samantha
    Foley, Stephen Ronan
    van Besien, Koen
    Wagner-Johnston, Nina D.
    Kersten, Maria Jose
    Schuster, Stephen J.
    Salles, Gilles
    Maziarz, Richard T.
    Anak, Ozlem
    Pacaud, Lida Bubuteishvili
    Gazi, Lucien
    Waldron, Edward
    Hamilton, Jason
    Pruteanu, Iulian
    Tai, Feng
    Mueller, Karen Thudium
    Waller, Edmund K.
    CANCER RESEARCH, 2018, 78 (13)
  • [36] Tafasitamab for the Treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the US Real-World Setting
    Saverno, Kimberly
    Savill, Kristin M. Zimmerman
    Feinberg, Bruce
    Galvin, John
    Pathak, Prathamesh
    Gordon, Sarah
    Amoloja, Theresa
    Llorente, Mae
    Epperla, Narendranath
    Nastoupil, Loretta J.
    BLOOD, 2023, 142
  • [37] Preferences and Perceptions Regarding Treatment Decision-Making for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
    Yung, Mallory
    Schnell, Frederick
    Vukcevic, Mirko
    Kurukulasuriya, Nuwan C.
    BLOOD, 2021, 138 : 1928 - +
  • [38] Prognostic Impact of Comorbidities on Outcomes of Patients (pts) with Relapsed or Refractory Large B-Cell Lymphoma (r/r LBCL) Treated with Chimeric Antigen Receptor T-Cell Therapy (CART)
    Greenbaum, Uri
    Hashmi, Hamza
    Elsawy, Mahmoud
    Kim, Soyoung
    Moskop, Amy
    Awan, Farrukh T.
    Farooq, Umar
    Ganguly, Siddhartha
    Hematti, Peiman
    Jain, Michael D.
    Kebriaei, Partow
    Locke, Frederick L.
    Mead, Elena
    Nishihori, Taiga
    Olson, Amanda L.
    Pennisi, Martina
    Perales, Miguel-Angel
    Geethakumari, Praveen Ramakrishnan
    Shouval, Roni
    Shpall, Elizabeth J.
    Magalhaes-Silverman, Margarida Magalhaes
    Strouse, Christopher
    Turtle, Cameron J.
    Vallurupalli, Anusha
    Wudhikam, Kitsada
    Pasquini, Marcelo C.
    Ahmed, Sairah
    Sorror, Mohamed
    BLOOD, 2022, 140 : 4636 - 4638
  • [39] Examination of Disparities in Access to Chimeric Antigen Receptor (CAR) T Cell Therapies in Medicare Patients (Pts) with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Who Had Failed at Least 2 Prior Lines of Therapy (LOT)
    Saunders, Ashley
    Inguva, Sushmitha
    Keating, Scott J.
    Chirikov, Viktor
    BLOOD, 2022, 140 : 10921 - 10923
  • [40] Analysis of Patterns of Failure and the Role of Bridging Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Treated with CAR T-Cell Therapy
    Ravella, R.
    Zhang-Velten, E. R.
    Awan, F.
    Rizvi, S.
    Shah, J. L.
    Desai, N. B.
    Geethakumari, P. Ramakrishnan
    Kumar, K. A., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E305 - E306
12345